Letters
Access to clinical trial data
Data monitoring committees and selective outcome reporting
BMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d635 (Published 01 February 2011) Cite this as: BMJ 2011;342:d635- Joseph Y Ting, clinical senior lecturer1
- 1Division of Anaesthesiology and Critical Care, University of Queensland, Brisbane, QLD 4067, Australia
- jysting{at}uq.edu.au
Selective outcome reporting leading to biased treatment and adverse effect estimates could be discerned by independent re-evaluation of full outcome data that are made publicly available after publication of a clinical trial.1 However, it would be more efficient to use data monitoring committees to do this …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.